PDCD1 and neoplasm: The purpose of inhibiting tumor growth was achieved by homotypic targeting of the H460 cell membrane and specific digestion by the MMP2 enzyme, delivering and releasing the TPP-1 peptide that inhibited PD-L1 and PD-1 binding into the tumor microenvironment [79].